China is suffering its most widespread Covid-19 outbreak since the virus first emerged at the beginning of the pandemic in Wuhan in 2019. The country’s new locally transmitted Covid cases have spiked to a near three-month high amid what the Chinese government called a ‘serious’ new outbreak of the highly infectious Delta variant. Now, more than 600 locally-transmitted cases have been found in 19 of the country’s 31 provinces, reports Bloomberg. The National Health Commission confirmed on Wednesday 93 new local symptomatic cases for Tuesday, up from 54 a day earlier and the highest daily count since August 9 at the peak of China’s last major outbreak. Most of the local cases were found in Heihe, a city in the northern province of Heilongjiang, where 35 infections were recorded on Tuesday. Three new provinces detected cases: central Chongqing, Jiangsu and Henan, reported Bloomberg. The spread and rise in Covid infections comes despite the Chinese government enforcing tighter curbs to contain the cases. Continue reading “China is suffering its most widespread Covid-19 outbreak since Wuhan”
Take Profits – My Two Most Favorite Words In The English Language
For those of you smart enough to be making the NASDAQ 100 trade I gave you, it’s time to take profits and take the cash off the table. If you traded exactly as we recommended and kept the trade all along, you profits should be over $75,000. Not bad but I promise we’ll do better. We will be back in this NASDAQ trade in short order.
We’re now in an oil trade that is showing profits so we are in a sweet spot. If you’d like to get these trades, please call Jim at 866-924-0607.
France’s daily COVID-19 infections top 7,000 for first time since mid-Sept… UK reports 41,278 new COVID cases, 166 deaths
PARIS (Reuters) – French health authorities reported 7,360 daily new COVID-19 infections on Saturday, the first time the tally has topped 7,000 since Sept 21. In another sign the virus is ramping up again, the seven-day moving average of daily new cases reached a more than one month high of 5,669. The cumulative total of new cases now stands at 7.16 million. Hospital cases – whose trend usually lags new case data by one to two weeks – were slightly down at 6,524 over 24 hours. But compared to last Saturday’s figure, the total is up by almost 200. The number of COVID-19 patients in intensive care rose by 5 in 24 hours to 1,039 and by 32 over a week. France also registered 22 new deaths from the epidemic, taking the total to 117,643.
UK reports 41,278 new COVID cases, 166 deaths
LONDON, Oct 30 (Reuters) – Britain reported 41,278 new COVID-19 cases on Saturday and 166 more deaths within 28 days of a positive test, official data showed. The figures compared to 43,467 new infections and 186 deaths reported on Friday.
China has another gift for you… Wuhan Virus cases and deaths surge again
CHINA
Wuhan Virus cases and deaths are surging for the first time in 2 months. 6 Million people are under lockdown in China, Russia has recorded its highest daily deaths, Tonga has recorded its first-ever case of the Wuhan Virus. Continue reading “China has another gift for you… Wuhan Virus cases and deaths surge again”
U.S. FDA authorizes first COVID-19 shot for young kids
https://youtu.be/9c-0mEV6hQE
(Reuters) -The U.S. Food and Drug Administration on Friday authorized the Pfizer Inc and BioNTech SE coronavirus vaccine for children aged 5 to 11 years, making it the first COVID-19 shot for young children in the United States.
The shot will not be immediately available to the age group. The U.S. Centers for Disease Control and Prevention still needs to advise on how the shot should be administered, which will be decided after a group of outside advisers discuss the plan on Tuesday. Continue reading “U.S. FDA authorizes first COVID-19 shot for young kids”
Impossible to control COVID-19 transmissions – Russian expert
MOSCOW, October 29. /TASS/. The time frames surrounding coronavirus becoming a seasonal disease are impossible to predict, Deputy Director of the Russian Central Research Institute of Epidemiology Alexander Gorelov said on Friday. “It is impossible to set any clear <…> deadlines that we can fight this infection by this date and it becomes seasonal. The process is multifactorial. <…> From my point of view, it is impossible to say in a specific time frame that tomorrow or a day after tomorrow, or in the foreseeable future the infection will be seasonal,” he said at the Eurasian Economic Forum. Gorelov added that there is no antiviral treatment in the world that can regulate the infection process. “On the other hand, if there is a vaccine, only 10% of the population has been vaccinated against the coronavirus infection. Do not forget about the phenomenon of the virus transmission to a nonimmune organism. The changes most often occur in the non-immune organism, as well as all its mutations that humanity faces over and over again,” he said. Earlier, chief of Russia’s sanitary watchdog, Anna Popova, said that the coronavirus would become a seasonal infection, like the flu.
Fluvoxamine cheap antidepressant shows promise fighting early stage covid19
Ever since the COVID-19 pandemic began, scientists have searched for an easily accessible medication that can help treat the virus. Merck recently announced that it is planning to seek an emergency use authorization from the Food and Drug Administration for its antiviral, molnupiravir. And now, it seems, there’s another promising—but surprising— medication that may be helpful in keeping high-risk patients out of the hospital: the antidepressant fluvoxamine. A large, placebo-controlled, randomized clinical trial published in The Lancet on Wednesday analyzed the effects of the drug, which is currently used to treat obsessive-compulsive disorder and depression, on patients with COVID-19. The researchers randomly assigned 741 patients fluvoxamine and 756 were given a placebo. The researchers discovered that the group that was given fluvoxamine were 1/3 less likely to need to be hospitalized or undergo prolonged medical observation than the placebo group. Some patients with COVID-19 stopped taking fluvoxamine over side effects but, in those who continued with the medication, one patient died compared to 12 who were given the placebo. Fluvoxamine also lowered the risk of patients being hospitalized by 2/3. Continue reading “Fluvoxamine cheap antidepressant shows promise fighting early stage covid19”
Low vitamin D and increased mortality
Lower levels of vitamin D, higher rates of death Association of Serum 25-Hydroxyvitamin D Concentrations With All-Cause and Cause-Specific Mortality Among Adult Patients With Existing Cardiovascular DiseaseObservational study, non-interventional
COVID boosters available to all Japanese citizens – report
Japan’s Ministry of Health has decided to offer COVID-19 vaccine boosters to all individuals who have already received two doses, after initially prioritizing frontline health workers and high-risk individuals, the Japanese press agency Jiji reported on Thursday. According to previous reports by Japanese media, Prime Minister Fumio Kishida’s plan involves administering the booster shots starting from December, in order to prevent the re-emergence of the virus as the country slowly goes back to pre-pandemic levels of activity. The Health Ministry’s timeline, which originally predicted distributing the third shot among those who have gone at least eight months since receiving their second dose and individuals at a higher risk of infection, is now altered to include all citizens.